Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria

BACKGROUND: Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health‐related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often or every night, which can lead to depression, anxiety, social, and work‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Giménez‐Arnau, Ana, Maurer, Marcus, Bernstein, Jonathan, Staubach, Petra, Barbier, Nathalie, Hua, Eva, Severin, Thomas, Joubert, Yolandi, Janocha, Reinhold, Balp, Maria‐Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848195/
https://www.ncbi.nlm.nih.gov/pubmed/35218324
http://dx.doi.org/10.1002/clt2.12121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848195/
https://www.ncbi.nlm.nih.gov/pubmed/35218324
http://dx.doi.org/10.1002/clt2.12121

Ejemplares similares